List of bibliographic references
Number of relevant bibliographic references: 5.
| Ident. | Authors (with country if any) | Title |
|---|
| 000006 (2016) |
Tatsuya Atsumi [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon] ; Hisashi Yamanaka [Japon] ; Naoki Ishiguro [Japon] ; Yoshiya Tanaka [Japon] ; Katsumi Eguchi [Japon] ; Akira Watanabe [Japon] ; Hideki Origasa [Japon] ; Shinsuke Yasuda [Japon] ; Yuji Yamanishi [Japon] ; Yasuhiko Kita [Japon] ; Tsukasa Matsubara [Japon] ; Masahiro Iwamoto [Japon] ; Toshiharu Shoji [Japon] ; Toshiyuki Okada [Japon] ; Désirée Van Der Heijde [Pays-Bas] ; Nobuyuki Miyasaka [Japon] ; Takao Koike [Japon] | The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. |
| 000127 (2015) |
Mette Bj Rndal Axelsen [Danemark] ; Iris Eshed [Israël] ; Kim H Rslev-Petersen [Danemark] ; Kristian Stengaard-Pedersen [Danemark] ; Merete Lund Hetland [Danemark] ; Jakob M Ller [Danemark] ; Peter Junker [Danemark] ; Jan P Denphant [Danemark] ; Annette Schlemmer [Danemark] ; Torkell Ellingsen [Danemark] ; Palle Ahlquist [Danemark] ; Hanne Lindegaard [Danemark] ; Asta Linauskas [Danemark] ; Mette Yde Dam [Danemark] ; Ib Hansen [Danemark] ; Hans Christian Horn [Danemark] ; Christian Gytz Ammitzb Ll [Danemark] ; Anette J Rgensen [Danemark] ; Sophine B. Krintel [Danemark] ; Johnny Raun [Danemark] ; Niels S. Krogh [Danemark] ; Julia Sidenius Johansen [Danemark] ; Mikkel Stergaard [Danemark] | A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. |
| 000184 (2014) |
Stinne Ravn Greisen ; Karen Kr Mmer Schelde ; Tue Kruse Rasmussen ; Tue Wenzel Kragstrup ; Kristian Stengaard-Pedersen ; Merete Lund Hetland ; Kim H Rslev-Petersen ; Peter Junker ; Mikkel Stergaard ; Bent Deleuran ; Malene Hvid | CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'. |
| 000192 (2014) |
Kim H Rslev-Petersen [Danemark] ; Merete Lund Hetland ; Peter Junker ; Jan P Denphant ; Torkell Ellingsen ; Palle Ahlquist ; Hanne Lindegaard ; Asta Linauskas ; Annette Schlemmer ; Mette Yde Dam ; Ib Hansen ; Hans Christian Horn ; Christian Gytz Ammitzb Ll ; Anette J Rgensen ; Sophine B. Krintel ; Johnny Raun ; Julia S. Johansen ; Mikkel Stergaard ; Kristian Stengaard-Pedersen | Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. |
| 000851 (????) |
Stinne Ravn Greisen [Danemark] ; Holger Jon M Ller [Danemark] ; Kristian Stengaard-Pedersen [Danemark] ; Merete Lund Hetland [Danemark] ; Kim H Rslev-Petersen [Danemark] ; Peter Junker [Danemark] ; Mikkel Stergaard [Danemark] ; Malene Hvid [Danemark] ; Bent Deleuran [Danemark] | Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Methotrexate"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i \
-Sk "Methotrexate" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= OperaV1
|flux= PubMed
|étape= Checkpoint
|type= indexItem
|index= MedMesh.i
|clé= Methotrexate
}}
| This area was generated with Dilib version V0.6.21.
Data generation: Thu Apr 14 14:59:05 2016. Site generation: Thu Jan 4 23:09:23 2024 |  |
